Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Aligos Therapeutics, Inc. (ALGS) Receiveable Turnover data is not available.
| Income Statement Financials | |
$15.53M |
|
$-87.68M |
|
-- |
|
$15.53M |
|
$103.66M |
|
$-88.13M |
|
$1.24M |
|
$-86.88M |
|
$-86.88M |
|
$-87.68M |
|
$-87.68M |
|
$-87.68M |
|
$-87.68M |
|
$-88.13M |
|
$-85.48M |
|
64.26M |
|
64.26M |
|
$-1.36 |
|
$-1.36 |
|
| Balance Sheet Financials | |
$141.08M |
|
$3.26M |
|
$10.44M |
|
$151.53M |
|
$23.91M |
|
$0.23M |
|
$35.54M |
|
$59.45M |
|
$92.08M |
|
$92.08M |
|
$92.08M |
|
75.10M |
|
| Cash Flow Statement Financials | |
$-79.00M |
|
$44.98M |
|
$88.33M |
|
$81.46M |
|
$135.77M |
|
$54.31M |
|
$12.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.90 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-567.50% |
|
-567.50% |
|
-550.47% |
|
-559.50% |
|
-564.61% |
|
$-79.02M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
|
Receiveable Turnover |
-- |
-- |
|
-95.22% |
|
-95.22% |
|
-57.86% |
|
-94.98% |
|
$1.23 |
|
$-1.23 |
|
$-1.23 |
|